by Benzinga Insights | Apr 29, 2026 | General
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 2.7% on an annualized basis producing an average annual return of 14.43%. Currently, Boston Scientific has a market capitalization of $86.91 billion. Buying $100 In BSX: If an investor...
by Benzinga Insights | Apr 29, 2026 | General
Cameco (NYSE:CCJ) has outperformed the market over the past 5 years by 33.22% on an annualized basis producing an average annual return of 44.44%. Currently, Cameco has a market capitalization of $50.74 billion. Buying $100 In CCJ: If an investor had bought $100 of...
by Benzinga Insights | Apr 29, 2026 | General
Advanced Micro Devices (NASDAQ:AMD) has outperformed the market over the past 20 years by 3.08% on an annualized basis producing an average annual return of 11.85%. Currently, Advanced Micro Devices has a market capitalization of $529.04 billion. Buying $100 In AMD:...
by Benzinga Insights | Apr 28, 2026 | General
Sensata Technologies (NYSE:ST) held its first-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit...
by Benzinga Insights | Apr 28, 2026 | General
Intuitive Surgical (NASDAQ:ISRG) has outperformed the market over the past 15 years by 6.39% on an annualized basis producing an average annual return of 18.12%. Currently, Intuitive Surgical has a market capitalization of $164.74 billion. Buying $1000 In ISRG: If an...
Recent Comments